Keywords: بیماری آلزایمر (AD); Graphene quantum dots; Neuroprotective peptide; Amyloid-β (Aβ); Dendritic spine; Alzheimer disease (AD);
مقالات ISI بیماری آلزایمر (AD) (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بیماری آلزایمر (AD); Magnetic resonance imaging (MRI); Alzheimer disease (AD); Positron emission tomography (PET); Frontotemporal lobar degeneration (FTLD); Lewy body dementia (LBD); Prion disease; Multiple sclerosis (MS); Vascular cognitive impairment;
Glutamatergic nervous system degeneration in a C. elegans TauA152T tauopathy model involves pathways of excitotoxicity and Ca2+ dysregulation
Keywords: بیماری آلزایمر (AD); Alzheimer disease (AD); Frontotemporal dementia (FTD); Tau pathology; Calreticulin; Caspase; Cathepsin; Necrosis; Insulin-signaling; 2N4R-Tau; largest isoform of human Tau in CNS (441 residues 2 inserts +4 repeats) accession: NP_005901.2 amino acid number
CommentaryGlobal Trends in Alzheimer Disease Clinical Development: Increasing the Probability of Success
Keywords: بیماری آلزایمر (AD); Alzheimer disease (AD); biomarker; drug development; early stage; mild cognitive impairment (MCI);
Nanoliposomes presenting on surface a cis-glycofused benzopyran compound display binding affinity and aggregation inhibition ability towards Amyloid β1-42 peptide
Keywords: بیماری آلزایمر (AD); Alzheimer disease (AD); Amyloid β (Aβ); Glycoderivatives; NMR interaction studies; Liposomes; Copper-free click chemistry
Electrochemical impedance spectroscopy analysis of A-beta (1-42) peptide using a nanostructured biochip
Keywords: بیماری آلزایمر (AD); electrochemical impedance spectroscopy (EIS); anodic aluminum oxide (AAO); A-beta (1-42) peptide; Alzheimer disease (AD); nanostructured biosensor
Reduced plasticity and mild cognitive impairment-like deficits after entorhinal lesions in hAPP/APOE4 mice
Keywords: بیماری آلزایمر (AD); Entorhinal cortex; Apolipoprotein E; Spatial navigation memory; Mild cognitive impairment; Alzheimer disease (AD); Acetylcholine; Dentate gyrus; Reactive synaptogenesis;
Ginkgo biloba
Keywords: بیماری آلزایمر (AD); Ginkgo biloba; EGb 761; Antioxidants; Cognitive impairment; Dementia; Alzheimer disease (AD); Anti-platelet-activating factor;
Elevation of glutathione as a therapeutic strategy in Alzheimer disease
Keywords: بیماری آلزایمر (AD); Alzheimer disease (AD); Mild cognitive impairment (MCI); Amyloid β-peptide; Glutathione (GSH); N-acetylcysteine (NAC); γ-Glutamylcysteine ethyl ester
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue
Keywords: بیماری آلزایمر (AD); Alzheimer disease (AD); amyloid beta (Aβ); Antibody; Affinity; Liposomes; Surface plasmon resonance (SPR)
Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide
Keywords: بیماری آلزایمر (AD); Alzheimer disease (AD); Amyloid beta (Aβ); Curcumin; Click chemistry; Structure; Liposomes
Efficacy of acetyl-cholinesterase-inhibitor (ACHEI) treatment in Alzheimer's disease: A 21-month follow-up “real world” study
Keywords: بیماری آلزایمر (AD); Acetyl-cholinesterase-inhibitor (ACHEI); Alzheimer disease (AD); Efficacy of ACHEI treatment; Observational study
Region-specific changes in the microanatomy of single dendritic spines over time might account for selective memory alterations in ageing hAPPsweTg2576 mice, a mouse model for Alzheimer disease
Keywords: بیماری آلزایمر (AD); Alzheimer disease (AD); Synaptic efficacy; Spine geometry; Tg2576 mice; Hippocampus; Dorsolateral striatum (DLS)
Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease
Keywords: بیماری آلزایمر (AD); Mild cognitive impairment (MCI); Alzheimer disease (AD); Phosphatidylserine (PtdSer); Phospholipid asymmetry; Apoptosis; Bax; Bcl-2; Caspase-3; Oxidative stress
Drug adverse events and drop-out risk: A clinical case
Keywords: بیماری آلزایمر (AD); Alzheimer disease (AD); Adverse drug reactions; Neuropsychology; Psychological interviews;
Multi-modal evoked potentials in corticobasal degeneration, progressive supranuclear palsy and Alzheimer disease
Keywords: بیماری آلزایمر (AD); Multi-modal evoked potentials; Corticobasal degeneration (CBD); Progressive supranuclear palsy (PSP); Alzheimer disease (AD);